$CRVS 3 SEC Filings

Filed On	Filing
27 Apr 2026	Form 3: Chan Andrew C., Director No securities owned
06 Oct 2025	Form 3: Moore David Scott, Director No securities owned
09 Apr 2025	Form 3: van den Broek Richard, Director Holds 160,000 shares of Common Stock
08 Feb 2024	Form 3: Arcara Jeffrey, Chief Business Officer No securities owned
22 Sep 2021	Form 3: EcoR1 Capital, Llc, 10% owner Holds 5,081,077 shares of Common Stock
15 Sep 2020	Form 3: Mitchell Edith P., Director No securities owned
06 May 2020	Form 3: Novo Holdings A/S, 10% owner Holds 2,927,560 shares of COMMON STOCK
30 Jan 2019	Form 3: Mobasher Mehrdad, Chief Medical Officer No securities owned
30 Jan 2019	Form 3: Grais Linda S, Director No securities owned
23 Jan 2018	Form 3: Buggy Joseph J, EVP Discovery Research Holds 84,876 shares of Common Stock, $0.0001 par value
15 Dec 2017	Form 3: Hunt Daniel W., SVP, Chief Business Officer No securities owned
04 Jan 2017	Form 3: Clark Ian T, Director No securities owned
10 Jun 2016	Form 3: Coloma Jason V, SVP, Chief Business Officer No securities owned
22 Mar 2016	Form 3: Jones William Benton, VP Pharmaceutical Development Holds 113,773 shares of Common Stock, $0.0001 par value
22 Mar 2016	Form 3: Adams Street Partners Llc, 10% owner
22 Mar 2016	Form 3: Lea Leiv, Chief Financial Officer Holds 156,645 shares of Common Stock, $0.0001 par value
22 Mar 2016	Form 3: Morrison Scott W, Director
22 Mar 2016	Form 3: Novo A/S, 10% owner
22 Mar 2016	Form 3: Krognes Steve E., Director No securities owned
22 Mar 2016	Form 3: Miller Richard A Md, Director Holds 718,228 shares of Common Stock, $0.0001 par value

Comments